Q3 2020 13F Holders as of 9/30/2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
432M
-
Number of holders
-
128
-
Total 13F shares, excl. options
-
155M
-
Shares change
-
+9.95M
-
Total reported value, excl. options
-
$6.5B
-
Value change
-
+$401M
-
Put/Call ratio
-
1.41
-
Number of buys
-
92
-
Number of sells
-
-55
-
Price
-
$42.07
Significant Holders of Royalty Pharma plc - Common Stock (RPRX) as of Q3 2020
172 filings reported holding RPRX - Royalty Pharma plc - Common Stock as of Q3 2020.
Royalty Pharma plc - Common Stock (RPRX) has 128 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 155M shares
of 432M outstanding shares and own 35.81% of the company stock.
Largest 10 shareholders include ADAGE CAPITAL PARTNERS GP, L.L.C. (46M shares), FMR LLC (18.2M shares), HARVARD MANAGEMENT CO INC (14.7M shares), Capital International Investors (10.4M shares), MORGAN STANLEY (9.37M shares), PRICE T ROWE ASSOCIATES INC /MD/ (8.23M shares), WELLINGTON MANAGEMENT GROUP LLP (5.7M shares), JANUS HENDERSON GROUP PLC (4.72M shares), JPMORGAN CHASE & CO (3.75M shares), and BlackRock Inc. (3.73M shares).
This table shows the top 128 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.